CATO 佳途CATO · CNAS + ANAB ISO 17034 双体系认可标准物质生产者CNAS + ANAB ISO 17034 dual-accredited reference material producer
销售顾问Sales contact 卢振明Kaka Lu+86 185 2048 1969kaka@cato-chem.com
Regorafenib

瑞戈非尼 杂质对照品Regorafenib Impurities

48 个杂质条目48 impurity entries

本页汇总 瑞戈非尼 的 48 个杂质对照品条目。杂质谱是仿制药杂质研究、方法开发与稳定性考察的起点——先锁定品种,再逐条比对结构差异与保留行为。This page collects 48 impurity reference standards of Regorafenib. The impurity profile is the starting point for related-substance method development, forced degradation and stability studies.

批量索取报价 / COABulk quote / COA在全站目录中检索Search the full catalogue

相关研究文献Related literature

以下为 瑞戈非尼(Regorafenib)在公开文献中的研究报道(题录信息,来源 PubMed),供方法开发与文献调研参考。Selected peer-reviewed publications on this drug substance — bibliographic records from PubMed.

  1. 杂质研究Impurity studiesDevelopment and validation of a simple and sensitive HPLC method for the determination of related substances in regorafenib tablets
    Analytical sciences : the international journal of the Japan Society for Analytical Chemistry · 2022 · Li S et al.  ·  PMID 35286636  ·  DOI
  2. 分析方法Analytical MethodsQuantification of cobimetinib, cabozantinib, dabrafenib, niraparib, olaparib, vemurafenib, regorafenib and its metabolite regorafenib M2 in human plasma by UPLC-MS/MS
    Biomedical chromatography : BMC · 2020 · Krens SD et al.  ·  PMID 31758580  ·  DOI
  3. 分析方法Analytical MethodsDevelopment of a UPLC-MS/MS method and its application for the pharmacokinetic analysis of regorafenib in rats
    Scientific reports · 2026 · Otto F et al.  ·  PMID 41720860  ·  DOI
  4. 分析方法Analytical MethodsA high throughput method for Monitoring of Sorafenib, regorafenib, cabozantinib and their metabolites with UPLC-MS/MS in rat plasma
    Frontiers in pharmacology · 2022 · Gu EM et al.  ·  PMID 36160432  ·  DOI
  5. 分析方法Analytical MethodsDevelopment and validation of an analytical method for regorafenib and its metabolites in mouse plasma
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences · 2018 · Fu Q et al.  ·  PMID 29783173  ·  DOI

瑞戈非尼 —— 原料药与杂质对照品Regorafenib — drug substance & impurities

共 49 个条目(含原料药本体)49 items incl. the drug substance
Regorafenib structure
原料药 APIAPI
瑞戈非尼Regorafenib
Regorafenib
CAS No.755037-03-7
Chemical FormulaC21H15ClF4N4O3
Purity>95%询价On request
10mg25mg50mg100mg
Regorafenib Impurity 1 structure
1
瑞戈非尼杂质1Regorafenib Impurity 1
Regorafenib Impurity 1
CAS No.2438857-80-6
Chemical FormulaC27H22F2N6O5
Purity>95%询价On request
10mg25mg50mg100mg
Regorafenib Impurity 2 structure
2
瑞戈非尼杂质2Regorafenib Impurity 2
Regorafenib Impurity 2
CAS No.1855006-12-0
Chemical FormulaC20H18FN5O3
Purity>95%询价On request
10mg25mg50mg100mg
Regorafenib Impurity 3 structure
3
瑞戈非尼杂质3Regorafenib Impurity 3
Regorafenib Impurity 3
CAS No.2098799-13-2
Chemical FormulaC35H23Cl2F7N6O5
Purity>95%询价On request
10mg25mg50mg100mg
Regorafenib Impurity 4 structure
4
瑞戈非尼杂质4Regorafenib Impurity 4
Regorafenib Impurity 4
CAS No.1187945-05-6
Chemical FormulaC20H12ClF4N3O4
Purity>95%询价On request
10mg25mg50mg100mg
Regorafenib Impurity 5 structure
5
瑞戈非尼杂质5Regorafenib Impurity 5
Regorafenib Impurity 5
CAS No.19448-54-5
Chemical FormulaC9H7ClF3NO2
Purity>95%询价On request
10mg25mg50mg100mg
Regorafenib Impurity 6 structure
6
瑞戈非尼杂质6Regorafenib Impurity 6
Regorafenib Impurity 6
CAS No.2188236-16-8
Chemical FormulaC21H16F4N4O3
Purity>95%询价On request
10mg25mg50mg100mg
Regorafenib Impurity 10 structure
10
瑞戈非尼杂质10Regorafenib Impurity 10
Regorafenib Impurity 10
CAS No.348-90-3
Chemical FormulaC9H7ClF3NO
Purity>95%询价On request
10mg25mg50mg100mg
Regorafenib Impurity 12 structure
12
瑞戈非尼杂质12Regorafenib Impurity 12
Regorafenib Impurity 12
CAS No.2518416-73-2
Chemical FormulaC22H12Cl2F7N3O3
Purity>95%询价On request
10mg25mg50mg100mg
Regorafenib Impurity 13 structure
13
瑞戈非尼杂质13Regorafenib Impurity 13
Regorafenib Impurity 13
CAS No.835621-11-9
Chemical FormulaC21H15ClF4N4O4
Purity>95%询价On request
10mg25mg50mg100mg
Regorafenib Impurity 14 structure
14
瑞戈非尼杂质14Regorafenib Impurity 14
Regorafenib Impurity 14
CAS No.835621-12-0
Chemical FormulaC20H13ClF4N4O4
Purity>95%询价On request
10mg25mg50mg100mg
Regorafenib Impurity 18 structure
18
瑞戈非尼杂质18Regorafenib Impurity 18
Regorafenib Impurity 18
CAS No.1379324-09-0
Chemical FormulaC7H6Cl2N2O
Purity>95%询价On request
10mg25mg50mg100mg
Regorafenib Impurity 21 structure
21
瑞戈非尼杂质21Regorafenib Impurity 21
Regorafenib Impurity 21
CAS No.1153328-25-6
Chemical FormulaC13H13N3O2
Purity>95%询价On request
10mg25mg50mg100mg
Regorafenib Impurity 23 structure
23
瑞戈非尼杂质23Regorafenib Impurity 23
Regorafenib Impurity 23
CAS No.2518234-85-8
Chemical FormulaC25H19F2N5O4
Purity>95%询价On request
10mg25mg50mg100mg
Regorafenib Impurity 24 structure
24
瑞戈非尼杂质24Regorafenib Impurity 24
Regorafenib Impurity 24
CAS No.370-50-3
Chemical FormulaC15H8Cl2F6N2O
Purity>95%询价On request
10mg25mg50mg100mg
Regorafenib Impurity 25 structure
25
瑞戈非尼杂质25Regorafenib Impurity 25
Regorafenib Impurity 25
CAS No.18585-06-3
Chemical FormulaC10H9ClF3NO2
Purity>95%询价On request
10mg25mg50mg100mg
Regorafenib Impurity 28 structure
28
瑞戈非尼杂质28Regorafenib Impurity 28
Regorafenib Impurity 28
CAS No.2755871-06-6
Chemical FormulaC24H16F3N3O4
Purity>95%询价On request
10mg25mg50mg100mg
Regorafenib Impurity 29 structure
29
瑞戈非尼杂质29Regorafenib Impurity 29
Regorafenib Impurity 29
CAS No.2817629-89-1
Chemical FormulaC12H9FN2O3
Purity>95%询价On request
10mg25mg50mg100mg
Regorafenib Impurity 31 structure
31
瑞戈非尼杂质31Regorafenib Impurity 31
Regorafenib Impurity 31
CAS No.1333390-56-9
Chemical FormulaC14H9ClF4N2O2
Purity>95%询价On request
10mg25mg50mg100mg
Regorafenib Impurity 33 structure
33
瑞戈非尼杂质33Regorafenib Impurity 33
Regorafenib Impurity 33
CAS No.2514957-39-0
Chemical FormulaC16H16FN3O4
Purity>95%询价On request
10mg25mg50mg100mg
Regorafenib Impurity 35 structure
35
瑞戈非尼杂质35Regorafenib Impurity 35
Regorafenib Impurity 35
CAS No.757251-39-1
Chemical FormulaC13H12FN3O2
Purity>95%询价On request
10mg25mg50mg100mg
Regorafenib Impurity 37 Monomer structure
37
瑞戈非尼杂质37 单体Regorafenib Impurity 37 Monomer
Regorafenib Impurity 37 Monomer
CAS No.2232228-54-3
Chemical FormulaC27H23ClF4N4O9
Purity>95%询价On request
10mg25mg50mg100mg
Regorafenib Impurity 38 structure
38
瑞戈非尼杂质38Regorafenib Impurity 38
Regorafenib Impurity 38
CAS No.1446410-29-2
Chemical FormulaC8H10ClN3O
Purity>95%询价On request
10mg25mg50mg100mg
Regorafenib Impurity 42 structure
42
瑞戈非尼杂质42Regorafenib Impurity 42
Regorafenib Impurity 42
CAS No.2545933-24-0
Chemical FormulaC25H22FN5O4
Purity>95%询价On request
10mg25mg50mg100mg
Regorafenib Impurity 45 structure
45
瑞戈非尼杂质45Regorafenib Impurity 45
Regorafenib Impurity 45
CAS No.2617653-26-4
Chemical FormulaC21H15ClF4N4O3
Purity>95%询价On request
10mg25mg50mg100mg
Regorafenib Impurity 50 structure
50
瑞戈非尼杂质50Regorafenib Impurity 50
Regorafenib Impurity 50
CAS No.496849-76-4
Chemical FormulaC7H4Cl3NO2
Purity>95%询价On request
10mg25mg50mg100mg
Regorafenib Impurity 51 structure
51
瑞戈非尼杂质51Regorafenib Impurity 51
Regorafenib Impurity 51
CAS No.350602-02-7
Chemical FormulaC7H4Cl3NO2
Purity>95%询价On request
10mg25mg50mg100mg
Regorafenib Impurity 52 structure
52
瑞戈非尼杂质52Regorafenib Impurity 52
Regorafenib Impurity 52
CAS No.35592-96-2
Chemical FormulaC7H3Cl4NO2
Purity>95%询价On request
10mg25mg50mg100mg
Regorafenib Impurity 55 structure
55
瑞戈非尼杂质55Regorafenib Impurity 55
Regorafenib Impurity 55
CAS No.200711-45-1
Chemical FormulaC7H4Cl3NO2
Purity>95%询价On request
10mg25mg50mg100mg
Regorafenib Impurity 58 structure
58
瑞戈非尼杂质58Regorafenib Impurity 58
Regorafenib Impurity 58
CAS No.2383703-22-6
Chemical FormulaC6H6FNO2
Purity>95%询价On request
10mg25mg50mg100mg
Regorafenib Impurity 59 structure
59
瑞戈非尼杂质59Regorafenib Impurity 59
Regorafenib Impurity 59
CAS No.2385452-26-4
Chemical FormulaC6H4FNO4
Purity>95%询价On request
10mg25mg50mg100mg
Regorafenib Impurity 62 structure
62
瑞戈非尼杂质62Regorafenib Impurity 62
Regorafenib Impurity 62
CAS No.56309-57-0
Chemical FormulaC8H3ClF3NO
Purity>95%询价On request
10mg25mg50mg100mg
Regorafenib Impurity 74 structure
74
瑞戈非尼杂质74Regorafenib Impurity 74
Regorafenib Impurity 74
CAS No.51488-21-2
Chemical FormulaC8H4ClF2NO
Purity>95%询价On request
10mg25mg50mg100mg
Regorafenib Impurity 76 structure
76
瑞戈非尼杂质76Regorafenib Impurity 76
Regorafenib Impurity 76
CAS No.90048-09-2
Chemical FormulaC7H6ClNO3
Purity>95%询价On request
10mg25mg50mg100mg
Regorafenib Impurity 79 structure
79
瑞戈非尼杂质79Regorafenib Impurity 79
Regorafenib Impurity 79
CAS No.1394953-73-1
Chemical FormulaC6H7FN2O
Purity>95%询价On request
10mg25mg50mg100mg
Regorafenib Impurity 81 structure
81
瑞戈非尼杂质81Regorafenib Impurity 81
Regorafenib Impurity 81
CAS No.2909-32-2
Chemical FormulaC14H14N2O
Purity>95%询价On request
10mg25mg50mg100mg
Regorafenib Impurity 82 structure
82
瑞戈非尼杂质82Regorafenib Impurity 82
Regorafenib Impurity 82
CAS No.394-41-2
Chemical Formula—
Purity>95%询价On request
10mg25mg50mg100mg
Regorafenib Impurity 83 structure
83
瑞戈非尼杂质83Regorafenib Impurity 83
Regorafenib Impurity 83
CAS No.399-95-1
Chemical FormulaC6H6FNO
Purity>95%询价On request
10mg25mg50mg100mg
Regorafenib Impurity 110 structure
110
瑞戈非尼杂质110Regorafenib Impurity 110
Regorafenib Impurity 110
CAS No.399-96-2
Chemical FormulaC6H6FNO
Purity>95%询价On request
10mg25mg50mg100mg
Regorafenib Impurity 114 structure
114
瑞戈非尼杂质114Regorafenib Impurity 114
Regorafenib Impurity 114
CAS No.583840-08-8
Chemical FormulaC20H14BrF3N4O4
Purity>95%询价On request
10mg25mg50mg100mg
Regorafenib Impurity 115 structure
115
瑞戈非尼杂质115Regorafenib Impurity 115
Regorafenib Impurity 115
CAS No.2230200-56-1
Chemical FormulaC17H17FN4O
Purity>95%询价On request
10mg25mg50mg100mg
Regorafenib Impurity 116 structure
116
瑞戈非尼杂质116Regorafenib Impurity 116
Regorafenib Impurity 116
CAS No.89246-40-2
Chemical FormulaC15H12N2O
Purity>95%询价On request
10mg25mg50mg100mg
Regorafenib Impurity 117 structure
117
瑞戈非尼杂质117Regorafenib Impurity 117
Regorafenib Impurity 117
CAS No.53981-24-1
Chemical FormulaC6H6FNO
Purity>95%询价On request
10mg25mg50mg100mg
Regorafenib Impurity 119 structure
119
瑞戈非尼杂质119Regorafenib Impurity 119
Regorafenib Impurity 119
CAS No.118-83-2
Chemical FormulaC7H3ClF3NO2
Purity>95%询价On request
10mg25mg50mg100mg
Regorafenib Impurity 120 structure
120
瑞戈非尼杂质120Regorafenib Impurity 120
Regorafenib Impurity 120
CAS No.2695513-53-0
Chemical FormulaC27H22F2N4O4
Purity>95%询价On request
10mg25mg50mg100mg
Regorafenib Impurity 122 structure
122
瑞戈非尼杂质122Regorafenib Impurity 122
Regorafenib Impurity 122
CAS No.39893-50-0
Chemical FormulaC8H3ClF3NO
Purity>95%询价On request
10mg25mg50mg100mg
Regorafenib Impurity 124 structure
124
瑞戈非尼杂质124Regorafenib Impurity 124
Regorafenib Impurity 124
CAS No.2206827-18-9
Chemical FormulaC28H25N7O6
Purity>95%询价On request
10mg25mg50mg100mg
Regorafenib Impurity 125 structure
125
瑞戈非尼杂质125Regorafenib Impurity 125
Regorafenib Impurity 125
CAS No.29091-09-6
Chemical FormulaC7HCl2F3N2O4
Purity>95%询价On request
10mg25mg50mg100mg
Regorafenib Impurity 13-d3 structure
13-D3
瑞戈非尼杂质13-d3Regorafenib Impurity 13-d3
Regorafenib Impurity 13-d3
CAS No.1333489-03-4
Chemical FormulaC21H12D3ClF4N4O4
Purity>95%询价On request

结构式清晰度以随货 COA 与厂家图谱为准;目录之外的杂质可按需定制合成或调取。Structural confirmation is governed by the COA and manufacturer spectra. Impurities outside this list can be custom-synthesised or sourced on request.

Literature & synthesis

瑞戈非尼 —— 研究文献与合成路线Regorafenib — literature & synthetic routes

以下题录由公开学术数据库按品种名检索汇总,供 瑞戈非尼 的杂质谱研究、分析方法开发与工艺路线选择参考。文献题名与专利标题均可点击查看原文,版权归原作者与出版方所有。Citations below are aggregated from public scholarly databases by drug-substance name, for reference in impurity profiling, analytical method development and route selection for Regorafenib. Titles link to the original records; copyright remains with the authors and publishers.

杂质与降解研究文献Impurity & degradation studies

  1. TRIM21 induces selective autophagic degradation of c-Myc and sensitizes regorafenib therapy in colorectal cancer
    Ye WL, Huang L, Yang XQ, et al. · Proceedings of the National Academy of Sciences of the United States of America · 2024 · 被引 47cited 47
  2. Regorafenib enhances anti-PDCD1/PD-1 therapeutic efficacy in colorectal cancer by promoting SQSTM1/p62-mediated CD274/PD-L1 degradation
    Zhu M, He Y, Lei S, et al. · Autophagy · 2026
  3. Analytical Quality by Design (AQbD)-Based Development and Validation of a Robust RP-HPLC Method for Quantification of Regorafenib in Bulk Drug and Tablet Dosage Form
    Chaudhary P, Bhorkhade S, Pakade I, et al. · 2026

合成路线文献Synthetic-route papers

  1. Synthesis and characterization of bevacizumab-functionalized nanoliposomes loaded with regorafenib and fluorescent carbon dots for triple-negative breast cancer theranostics
    Aryanmanesh A, Abbasi Kajani A · RSC advances · 2026
  2. Efficacy and Safety of Regorafenib with or without Immune Checkpoint Inhibitors as Second-Line Treatment for Advanced Hepatocellular Carcinoma: A Systematic Review and Arm-Level Synthesis of Real-World Comparative Cohorts
    Yu X, Zan H, Deng W, et al. · OncoTargets and therapy · 2026
  3. A patent review on efficient strategies for the total synthesis of pazopanib, regorafenib and lenvatinib as novel anti-angiogenesis receptor tyrosine kinase inhibitors for cancer therapy
    Shiri P, Ramezanpour S, Amani AM, et al. · Molecular diversity · 2022

题录与链接来自公开数据库 Europe PMC(含 PubMed 与全球专利题录)与 WIPO PatentScope,本站仅提供索引,不转载正文;如链接失效请以数据库检索为准。Citations are indexed from public databases (Europe PMC incl. PubMed and patent records, WIPO PatentScope); we provide links only and do not reproduce full text.

For formulation & analytical R&D

瑞戈非尼 杂质谱研究要点Regorafenib — impurity profiling notes

下面这些是拿到 瑞戈非尼 的 49 个杂质条目之后,仿制药研发最常遇到的几件事。先把杂质的来源分清,再决定要不要买对照品、买哪几个。Once you have the 49 impurity entries for Regorafenib, these are the questions that come up most in generic development. Classify the source of each impurity first, then decide which reference standards you actually need.

01工艺杂质Process impurities

起始物料、中间体、副产物、催化剂与溶剂残留。多来自合成路线本身,应在工艺开发阶段用加标试验定位。Starting materials, intermediates, by-products, catalysts and residual solvents — traced back to the synthetic route and located with spiking studies during process development.

02降解杂质Degradation impurities

水解、氧化、光解、高温高湿与聚合产物。需通过强制降解试验识别,并确认方法具备稳定性指示能力。Hydrolytic, oxidative, photolytic, thermal and polymeric degradants — identified through forced degradation, with the method proven stability-indicating.

03药典杂质Pharmacopoeial impurities

EP/USP 已收载并有官方编号的杂质(如 EP Impurity A、USP Related Compound B)。申报时通常需逐项对照。Impurities already monographed with official designations (e.g. EP Impurity A, USP Related Compound B), normally compared item by item during filing.

04基因毒性杂质Genotoxic impurities

含警示结构、需按 ICH M7 进行危害评估与限度推导(TTC 1.5 µg/日)。该类杂质必须用对照品准确控制。Structurally alerting compounds requiring ICH M7 hazard assessment and limit derivation (TTC 1.5 µg/day); these must be controlled with an authentic reference standard.

05同位素标记物Isotopically labelled standards

氘代、¹³C、¹⁵N 标记的同类物,主要用作 LC-MS/MS 生物分析的内标,抵消基质效应与回收率波动。Deuterated, ¹³C- and ¹⁵N-labelled analogues used as internal standards in LC-MS/MS bioanalysis to compensate matrix effects and recovery variation.

06代谢与转化产物Metabolites & conversion products

体内代谢物、强制降解转化物与工艺中间态,常见于杂质谱比对与稳定性考察中。In-vivo metabolites, forced-degradation products and process intermediates encountered in impurity profiling and stability studies.

方法开发与对照品使用建议Method development and standards usage

先定分离,再谈定量Resolution first, then quantification

主成分与相邻杂质峰分离度应 ≥1.5;用杂质对照品确定相对保留时间与相对响应因子,避免用自身对照法掩盖响应差异。Target baseline resolution ≥1.5 between the main component and adjacent impurities; establish relative retention and relative response factors with authentic impurity standards rather than relying on self-comparison.

校正因子不可忽略Never ignore response factors

紫外吸收差异大的杂质必须校正,否则定量结果系统性偏低或偏高。EP/USP 已给出校正因子的按药典执行。Impurities with markedly different UV response need correction, otherwise results are systematically biased. Where EP/USP publish a correction factor, follow the monograph.

强制降解要做全Run the full forced-degradation panel

建议覆盖酸、碱、氧化(H₂O₂)、光照(ICH Q1B)、高温高湿;主峰纯度用二极管阵列或质谱确认。Cover acid, base, peroxide oxidation, photostability (ICH Q1B) and heat/humidity; confirm peak purity by DAD or MS.

定义报告阈值Set reporting and identification thresholds

按 ICH Q3A/Q3B 设定报告阈值、鉴定阈值与界定阈值,避免为无意义的峰投入过多工作量。Apply ICH Q3A/Q3B reporting, identification and qualification thresholds so effort is not spent on insignificant peaks.

标准品储存有讲究Store standards properly

杂质对照品多建议 −20 ℃ 避光、干燥、密封保存;溶液现配现用,并记录开瓶与配制日期。Most impurity standards should be stored at −20 °C, protected from light and moisture; prepare solutions fresh and record opening and preparation dates.

用结构式先做初判Start from the structure

先比对杂质与主成分的结构差异,可预判其保留行为、紫外响应与可能的降解路径,能显著减少试错。Comparing the impurity structure with the parent drug predicts retention behaviour, UV response and probable degradation routes, cutting trial and error.

以上为通行的杂质研究实践提示,不针对具体品种给出结论。实际限度、校正因子与色谱条件请以 EP/USP 各论及你们的验证数据为准。需要某个杂质的结构确证资料、COA 或定制合成,可直接联系我们。The above are general impurity-profiling notes and are not conclusions about this specific drug substance. Actual limits, correction factors and chromatographic conditions follow the EP/USP monograph and your own validation data. Contact us for structural confirmation data, COAs or custom synthesis.
索取杂质谱报价 / COARequest a quote / COA← 查看其它品种← Other drug substances